Circulating tumor DNA (ctDNA) is frequently vastly outnumbered by the amount of non-cancer DNA in the blood, especially in cancers with a low tumor burden, or in certain types of cancer such as gliomas and renal cancers. Improving detection methods is of paramount importance to allow the identification of the early stages of cancer through […]
The post Breaking New Ground in Liquid Biopsy appeared first on GEN - Genetic Engineering and Biotechnology News.
Original Article: Breaking New Ground in Liquid Biopsy